tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
Advertisement

Kymera Therapeutics (KYMR) Ownership - Who Owns Kymera Therapeutics?

Compare
350 Followers

Kymera Therapeutics (KYMR) Ownership Overview

11.97%29.59%0.72%12.56%45.16%
11.97% Insiders
0.72% Other Institutional Investors
12.56% ETFs
45.16% Public Companies and
Individual Investors
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 42.87% of the company’s stock is owned by Institutional Investors, 11.97% is owned by Insiders, and 45.16% is owned by Public Companies and Individual Investors.
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 30.31% of the company’s stock is owned by Institutional Investors, 11.97% is owned by Insiders, and 12.56% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 01, 2025
xxxxxxxxxxxxx
$13955348
Jun 30, 2025
xxxxxxxxxxxxx
$28842000
Mar 03, 2025
xxxxxxxxxxxxx
$42104
Mar 03, 2025
xxxxxxxxxxxxx
$214172

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$1474901
Jun 30, 2025
xxxxxxxxxxxxx
$9169025
Jun 30, 2025
xxxxxxxxxxxxx
$14358432
Jun 30, 2025
xxxxxxxxxxxxx
$21737564

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,651,429Institution9.30%283,550,418
6,117,295Insider8.56%260,780,286
5,463,122Institution7.64%232,892,891
4,631,163Institution6.48%197,426,479
3,051,818Institution4.27%130,099,001
3,013,587Institution4.21%128,469,214
2,275,089Institution3.18%96,987,044
2,098,006Institution2.93%89,437,996
1,208,485Institution1.69%51,517,716
977,897Institution1.37%41,687,749

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,631,163Institution6.48%197,426,479
3,051,818Institution4.27%130,099,001
3,013,587Institution4.21%128,469,214
2,275,089Institution3.18%96,987,044
1,208,485Institution1.69%51,517,716
977,897Institution1.37%41,687,749
600,500Institution0.84%25,599,315
525,138Institution0.73%22,386,633
515,322Institution0.72%21,968,177
479,525Institution0.67%20,442,151

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,878,372Institution2.63%82,178,775
1,449,270Institution2.03%63,405,563
1,120,359Institution1.57%47,760,904
818,184Institution1.14%35,795,550
557,690Institution0.78%24,398,938
508,835Institution0.71%21,142,094
411,336Institution0.58%17,535,254
328,993Institution0.46%14,024,972
245,032Institution0.34%10,181,080
223,019Institution0.31%9,757,081

FAQ

Who Owns Kymera Therapeutics (KYMR)?
According to the latest TipRanks data, approximately 0.72% of the company's stock is held by institutional investors, 11.97% is held by insiders, and 45.16% is held by retail investors.
    What percentage of Kymera Therapeutics (KYMR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.72% of Kymera Therapeutics (KYMR) stock is held by institutional investors.
      What percentage of Kymera Therapeutics (KYMR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 45.16% of Kymera Therapeutics (KYMR) stock is held by retail investors.
        Who owns the most shares of Kymera Therapeutics (KYMR)?
        Felix Baker owns the most shares of Kymera Therapeutics (KYMR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis